Loading
Led the trials comparing stereotactic radiotherapy with surgery for operable early lung cancer.
Joe Chang led the pooled STARS and ROSEL analysis and the revised STARS trial suggesting stereotactic ablative radiotherapy matches lobectomy for operable stage I NSCLC, results that opened the surgery-versus-SABR debate. He directs thoracic radiation oncology at MD Anderson and studies proton therapy and radiotherapy-immunotherapy combinations.
Shares SBRT / SABR (stereotactic radiotherapy), Non-small-cell lung cancer and the tags radiotherapy, sbrt, lung.
Shares Proton therapy, Non-small-cell lung cancer and the tags radiotherapy, lung.
Shares SBRT / SABR (stereotactic radiotherapy), Non-small-cell lung cancer and the tags radiotherapy, lung.
Shares SBRT / SABR (stereotactic radiotherapy), Non-small-cell lung cancer.
Shares SBRT / SABR (stereotactic radiotherapy), Non-small-cell lung cancer.
Shares SBRT / SABR (stereotactic radiotherapy), Non-small-cell lung cancer.
Shares SBRT / SABR (stereotactic radiotherapy) and the tags radiotherapy, sbrt.
Shares SBRT / SABR (stereotactic radiotherapy) and the tags radiotherapy, sbrt.